Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.56
Delayed Data
As of Jul 28
 0.00 / 0.00%
Today’s Change
0.29
Today|||52-Week Range
1.22
-20.00%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close0.56
Today’s open0.56
Day’s range0.54 - 0.59
Volume36,244
Average volume (3 months)59,321
Market cap$79.4M
Dividend yield--
Data as of 3:55pm ET, 07/28/2016

Growth & Valuation

Earnings growth (last year)+68.75%
Earnings growth (this year)+26.67%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book42.30

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...+0.01+0.62%
ATNMActinium Pharmaceuti...+0.05+2.94%
EBIOEleven Biotherapeuti...+0.41+10.35%
MBRXMoleculin Biotech In...-0.07-1.00%
Data as of 4:02pm ET, 07/28/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Class I Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts

Partner Offers

Search for Jobs